Coffee intake and chronic hepatitis C.
Purnak
Tugrul
T
Ozaslan
Ersan
E
D000998:Antiviral Agents / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D003069:Coffee; D019388:Cytochrome P-450 CYP1A2 / Q000378:metabolism; D018450:Disease Progression; D004327:Drinking Behavior / Q000502:physiology; D004347:Drug Interactions; D019698:Hepatitis C, Chronic / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use
D000998:Antiviral Agents; D003069:Coffee; D010726:Phosphodiesterase Inhibitors; D002110:Caffeine; D019388:Cytochrome P-450 CYP1A2